Literature DB >> 14690185

Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity.

Abdullah Dogan1, Bahattin Tunc, Oktay Ergene, Mehmet Ozaydin, Cem Nazli, Ahmet Altinbas, Omer Gedikli.   

Abstract

OBJECTIVE: Since the role of fibrinolytic activity is unclear in coronary artery ectasia, we investigated the entire fibrinolytic activity by a new test, global fibrinolytic capacity (GFC) in the ectasia patients. METHODS AND
RESULTS: Thirty-four ectasia patients (18 male, mean age: 58 +/- 8 years) presenting with acute coronary syndrome and 25 controls (14 male, mean age: 56 +/- 9 years) with normal coronary artery were evaluated. GFC, D-dimer and other hemostatic factors were assessed. Clinical characteristics were comparable in both groups. Serum GFC (4.6 +/- 2.1 vs. 3.1 +/- 2.1 microg/ml, p = 0.03) and D-dimer levels (0.69 +/- 0.42 vs. 0.41 +/- 0.38 ng/ml, p = 0.02, respectively) were significantly higher in ectasia patients than in controls. They were also higher in subgroup of patients with myocardial infarction (four patients) compared with other ectasia patients and controls (p = 0.04, 0.01, respectively). Other hemostatic factors were not different in both groups. GFC was correlated with D-dimer (r = 0.76, p = 0.01).
CONCLUSION: Our results suggest that fibrinolytic system activation may develop in ectasia patients with acute coronary syndrome. It can be induced by thrombus formation in ectatic segment of coronary artery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690185     DOI: 10.1023/b:caim.0000004339.30038.8d

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  23 in total

Review 1.  Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.

Authors:  G D Lowe; A Rumley
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Effect of temperature and incubation time on D-dimer serum levels in healthy subjects.

Authors:  D Prisco; R Paniccia; B Bandinelli; A A Liotta; S Fedi; B Giusti; G Pepe; R Abbate
Journal:  Thromb Res       Date:  2000-03-15       Impact factor: 3.944

3.  Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D Lowe
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

4.  Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

Authors:  I Juhan-Vague; S D Pyke; M C Alessi; J Jespersen; F Haverkate; S G Thompson
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

5.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; W D Rosamond; A R Sharrett; L E Chambless
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

Authors:  M Cushman; R N Lemaitre; L H Kuller; B M Psaty; E M Macy; A R Sharrett; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

7.  Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.

Authors:  M Nikfardjam; S Graf; R Beckmann; S Hornykewycz; J Koller-Strametz; B R Binder; K Huber
Journal:  Thromb Haemost       Date:  1999-09       Impact factor: 5.249

8.  Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

Authors:  P M Ridker; D E Vaughan; M J Stampfer; J E Manson; C H Hennekens
Journal:  Lancet       Date:  1993-05-08       Impact factor: 79.321

9.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.

Authors:  B O Olofsson; G Dahlén; T K Nilsson
Journal:  Eur Heart J       Date:  1989-01       Impact factor: 29.983

10.  Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.

Authors:  Abdullah Dogan; Mehmet Ozaydin; Omer Gedikli; Ahmet Altinbas; Oktay Ergene
Journal:  Jpn Heart J       Date:  2003-07
View more
  2 in total

1.  Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.

Authors:  Diego Araiza-Garaygordobil; Rodrigo Gopar-Nieto; Daniel Sierra-Lara Martínez; Nallely Belderrain-Morales; Vianney Sarabia-Chao; Diana Laura Alfaro-Ponce; Heriberto Ontiveros-Mercado; Salvador Mendoza-García; Alfredo Altamirano-Castillo; Pablo Martinez-Amezcua; Alejandro Cabello-López; Jose Luis Briseño-De la Cruz; Maximiliano Ruiz-Beltrán; Marco Antonio Martínez-Ríos; Yigal Piña-Reyna; Hector Gonzalez-Pacheco; Alexandra Arias-Mendoza
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-07-29

2.  Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.

Authors:  Wei Wu; Ruifeng Liu; Lianfeng Chen; Houzao Chen; Shuyang Zhang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.